OncoVista Innovative Therapies, Inc.
OTC: OVIT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alexander L. Weis
- Employees
- 2
- Headquarters
- San Antonio, United States
- IPO year
- 2007
- Market cap
- $2.4K
- Website
- https://www.oncovita.com
Loading OVIT…
Loading profile data…Frequently asked questions about OVIT
What does OncoVista Innovative Therapies, Inc. (OVIT) do?
OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.
Where does OVIT trade?
OncoVista Innovative Therapies, Inc. (OVIT) trades on the Other OTC.
What sector is OVIT in?
OncoVista Innovative Therapies, Inc. (OVIT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of OncoVista Innovative Therapies, Inc.?
Alexander L. Weis is the chief executive officer of OncoVista Innovative Therapies, Inc. (OVIT).
Where is OncoVista Innovative Therapies, Inc. headquartered?
OncoVista Innovative Therapies, Inc. is headquartered in United States.
Does OVIT pay a dividend?
OncoVista Innovative Therapies, Inc. (OVIT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OVIT go public?
OncoVista Innovative Therapies, Inc. (OVIT) completed its initial public offering in 2007.